Ocular Therapeutix Inc (OCUL)
5.595
+0.56
(+11.23%)
USD |
NASDAQ |
May 02, 12:27
Ocular Therapeutix Shares Outstanding: 148.63M for March 6, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 06, 2024 | 148.63M |
December 31, 2023 | 114.96M |
December 18, 2023 | 114.84M |
November 03, 2023 | 79.42M |
September 30, 2023 | 79.41M |
August 03, 2023 | 79.38M |
June 30, 2023 | 79.23M |
May 04, 2023 | 77.52M |
April 21, 2023 | 77.52M |
March 31, 2023 | 77.52M |
March 01, 2023 | 77.51M |
December 31, 2022 | 77.20M |
November 04, 2022 | 77.01M |
September 30, 2022 | 77.01M |
August 05, 2022 | 76.97M |
June 30, 2022 | 76.91M |
May 06, 2022 | 76.76M |
April 19, 2022 | 76.76M |
March 31, 2022 | 76.76M |
February 24, 2022 | 76.75M |
December 31, 2021 | 76.73M |
November 03, 2021 | 76.61M |
September 30, 2021 | 76.61M |
August 04, 2021 | 76.58M |
July 31, 2021 | 76.58M |
Date | Value |
---|---|
June 30, 2021 | 76.45M |
May 01, 2021 | 76.29M |
April 19, 2021 | 76.29M |
April 01, 2021 | 76.24M |
March 31, 2021 | 76.24M |
March 02, 2021 | 76.07M |
March 01, 2021 | 76.07M |
December 31, 2020 | 76.00M |
December 28, 2020 | 75.86M |
December 18, 2020 | 75.30M |
November 30, 2020 | 71.58M |
November 01, 2020 | 71.39M |
October 16, 2020 | 71.33M |
September 30, 2020 | 63.07M |
August 01, 2020 | 62.96M |
June 30, 2020 | 62.95M |
May 22, 2020 | 62.77M |
May 01, 2020 | 53.36M |
April 30, 2020 | 53.36M |
April 27, 2020 | 53.36M |
April 15, 2020 | 53.04M |
March 31, 2020 | 53.04M |
March 25, 2020 | 52.58M |
March 02, 2020 | 52.58M |
December 31, 2019 | 50.33M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
42.84M
Minimum
May 09 2019
148.63M
Maximum
Mar 06 2024
72.00M
Average
76.29M
Median
Apr 19 2021
Shares Outstanding Benchmarks
Amgen Inc | 535.92M |
Assertio Holdings Inc | 95.00M |
CytomX Therapeutics Inc | 67.72M |
EyePoint Pharmaceuticals Inc | 49.83M |
Regeneron Pharmaceuticals Inc | 109.76M |